OptiBiotix Health (LON:OPTI) Shares Down 10.6% – What’s Next?

OptiBiotix Health Plc (LON:OPTI) traded down 10.6% on Wednesday. The company traded as low as GBX 4.55 and last traded at GBX 4.56. 537,026 shares were traded during mid-day trading, an increase of 72% from the average daily volume of 311,584 shares. The stock had previously closed at GBX 5.10.

OptiBiotix Health Trading Down 10.6%

The firm has a market capitalization of £4.71 million, a P/E ratio of -1.08 and a beta of 1.82. The company has a 50-day moving average of GBX 5.82 and a 200-day moving average of GBX 5.89.

OptiBiotix Health (LON:OPTI) last issued its quarterly earnings results on Thursday, September 17th. The company reported GBX (1.52) earnings per share for the quarter. OptiBiotix Health had a negative net margin of 332.69% and a negative return on equity of 77.85%.

About OptiBiotix Health

OptiBiotix Health plc (AIM: OPTI), which was formed in March 2012, brings science to the development of compounds which modify the human microbiome – the collective genome of the microbes in the body – in order to prevent and manage human disease and promote wellness. OptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements. More than twenty international food and healthcare supplement companies have signed agreements with OptiBiotix to incorporate their human microbiome modulators into a wide range of food products and drinks.